Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation

Blood. 1993 Feb 1;81(3):865.

Authors

J Nemunaitis, C Anasetti, C D Buckner, F R Appelbaum, K Shannon-Dorcy, J Hansen, J W Singer

PMID: 8427980

No abstract available

Publication types

Letter

MeSH terms

Adult
Anemia, Aplastic / surgery
Bone Marrow Transplantation*
Follow-Up Studies
Graft vs Host Disease / epidemiology
Graft vs Host Disease / prevention & control*
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Incidence
Leukemia, Lymphocytic, Chronic, B-Cell / surgery
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery
Leukocyte Count / drug effects
Lymphoma / surgery
Platelet Count / drug effects
Recombinant Proteins / therapeutic use*
Time Factors

Substances

Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor